USD 1.12
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| TLRY | -0.9 | -5.9 | -21.7 | -33.3 | -40.7 | -44.8 | -80.8 | -94.7 | -95.0 | -95.0 |
| S&P 500 | 0.5 | 2.1 | 2.4 | 5.5 | 10.1 | 25.8 | 38.7 | 84.0 | 198.2 | 34547.3 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | TLRY |
| name | Tilray Brands, Inc. |
| price | 1.12 |
| changes percentage | -0.885 |
| change | -0.01 |
| day low | 1.11 |
| day high | 1.15 |
| year high | 2.97 |
| year low | 1.11 |
| market cap | 1050173600 |
| price avg 50 | 1.3186 |
| price avg 200 | 1.68145 |
| exchange | NASDAQ |
| volume | 41913493 |
| avg volume | 34819771 |
| open | 1.13 |
| previous close | 1.13 |
| eps | -0.3 |
| pe | -3.73 |
| earnings announcement | 2025-04-07T12:00:00.000+0000 |
| shares outstanding | 937655000 |
| timestamp | 2025-01-23 21:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001731348 | |||
| revenue | 788942000 | 627124000 | 25.80 |
| gross profit | 223351000 | 146960000 | 51.98 |
| gross profit ratio | 0.28 | 0.23 | 20.81 |
| research and development expenses | 635000 | 682000 | -6.89 |
| operating expenses | 398096000 | 325107000 | 22.45 |
| interest income | 12831000 | 33025000 | -61.15 |
| interest expense | 49264000 | 13587000 | 262.58 |
| ebitda | -72843000 | -889521000 | 91.81 |
| ebitdaratio | -0.09 | -0.18 | 49.61 |
| operating income | -174745000 | -1369685000 | 87.24 |
| operating income ratio | -0.22 | -2.18 | 89.86 |
| net income | -244981000 | -1443000000 | 83.02 |
| net income ratio | -0.31 | -2.3 | 86.50 |
| eps | -0.33 | -2.34 | 85.90 |
Revenue Growth: revenue increased to 789 million in 2024 from 627 million in 2023 representing a change of 25.8%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 223 million in 2024 from 147 million in 2023 representing a change of 51.98%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Income: Operating income increased to -175 million in 2024 from -1,370 million in 2023 representing a change of 87.24%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -245 million in 2024 from -1,443 million in 2023 representing a change of 83.02%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.33 in 2024 from -0.33 in 2023 representing a change of 85.9%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 1 million in 2024 from 1 million in 2023 representing a change of -6.89%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Expenses: Operating Expenses increased to 398 million in 2024 from 325 million in 2023 representing a change of 22.45%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -73 million in 2024 from -890 million in 2023 representing a change of 91.81%. The decrease in EBITDA indicates declined operational efficiency and profitability.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001731348 | |||
| revenue | 210950000 | 200044000 | 5.45 |
| gross profit | 61220000 | 59706000 | 2.54 |
| gross profit ratio | 0.29 | 0.3 | -2.77 |
| research and development expenses | 60000 | 105000 | -42.86 |
| operating expenses | 103438000 | 96276000 | 7.44 |
| interest income | 0 | 0 | NaN |
| interest expense | 7766000 | 9842000 | -21.09 |
| ebitda | -41423000 | 7889999 | -625.01 |
| ebitdaratio | -0.2 | 0.04 | -597.86 |
| operating income | -42218000 | -36570000 | -15.44 |
| operating income ratio | -0.2 | -0.18 | -9.48 |
| net income | -85275000 | -39165000 | -117.73 |
| net income ratio | -0.4 | -0.2 | -106.48 |
| eps | -0.1 | -0.04 | -120.58 |
Revenue Growth: revenue increased to 211 million in 2025Q2 from 200 million in 2025Q1 representing a change of 5.45%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 61 million in 2025Q2 from 60 million in 2025Q1 representing a change of 2.54%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2025Q2 from 0 million in 2025Q1 representing a change of -42.86%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
Operating Expenses: Operating Expenses decreased to 103 million in 2025Q2 from 96 million in 2025Q1 representing a change of 7.44%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Operating Income: Operating income increased to -42 million in 2025Q2 from -37 million in 2025Q1 representing a change of -15.44%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -85 million in 2025Q2 from -39 million in 2025Q1 representing a change of -117.73%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -41 million in 2025Q2 from 8 million in 2025Q1 representing a change of -625.01%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Earnings per Share (EPS): EPS increased to -0.1 in 2025Q2 from -0.1 in 2025Q1 representing a change of -120.58%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001731348 | |||
| total assets | 4221665000 | 4307259000 | -1.99 |
| total liabilities | 778487000 | 977316000 | -20.34 |
| total equity | 3443178000 | 3329943000 | 3.40 |
| cash and cash equivalents | 228340000 | 206632000 | 10.51 |
| short term investments | 32182000 | 241897000 | -86.70 |
| long term investments | 7859000 | 12371000 | -36.47 |
| total current assets | 677710000 | 773029000 | -12.33 |
| total non current assets | 3657585000 | 3534230000 | 3.49 |
| total current liabilities | 299170000 | 432979000 | -30.90 |
| total non current liabilities | 592946999 | 544337000 | 8.93 |
| common stock | 83000 | 66000 | 25.76 |
| retained earnings | -2660488000 | -2415507000 | -10.14 |
| total debt | 387317000 | 590131000 | -34.37 |
Total Assets: Total Assets decreased to 4,222 million in 2024 from 4,307 million in 2023 representing a change of -1.99%. Suggesting a decrease in asset holdings.
Short Term Investments: Short Term Investments decreased to 32 million in 2024 from 242 million in 2023 representing a change of -86.7%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 678 million in 2024 from 773 million in 2023 representing a change of -12.33%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -2,660 million in 2024 from -2,416 million in 2023 representing a change of -10.14%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 778 million in 2024 from 977 million in 2023 representing a change of -20.34%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 3,443 million in 2024 from 3,330 million in 2023 representing a change of 3.4%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 228 million in 2024 from 207 million in 2023 representing a change of 10.51%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 299 million in 2024 from 433 million in 2023 representing a change of -30.9%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2024 from 0 in 2023 representing a change of 25.76%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 387 million in 2024 from 590 million in 2023 representing a change of -34.37%. This indicates a reduction in overall debt burden.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001731348 | |||
| total assets | 4191754000 | 4261867000 | -1.65 |
| total liabilities | 738146000 | 778453000 | -5.18 |
| total equity | 3472928000 | 3483414000 | -0.30 |
| cash and cash equivalents | 189698000 | 205186000 | -7.55 |
| short term investments | 62551000 | 74869000 | -16.45 |
| long term investments | 7416000 | 7853000 | -5.56 |
| total current assets | 707339000 | 725883000 | -2.55 |
| total non current assets | 3484415000 | 3535984000 | -1.46 |
| total current liabilities | 278524000 | 293549000 | -5.12 |
| total non current liabilities | 459622000 | 484904000 | -5.21 |
| common stock | 93000 | 88000 | 5.68 |
| retained earnings | -2784995000 | -2699653000 | -3.16 |
| total debt | 373791000 | 388421000 | -3.77 |
Total Assets: Total Assets decreased to 4,192 million in 2025Q2 from 4,262 million in 2025Q1 representing a change of -1.65%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 3,473 million in 2025Q2 from 3,483 million in 2025Q1 representing a change of -0.3%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 190 million in 2025Q2 from 205 million in 2025Q1 representing a change of -7.55%. This indicates a decrease in available liquid assets.
Short Term Investments: Short Term Investments decreased to 63 million in 2025Q2 from 75 million in 2025Q1 representing a change of -16.45%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 707 million in 2025Q2 from 726 million in 2025Q1 representing a change of -2.55%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -2,785 million in 2025Q2 from -2,700 million in 2025Q1 representing a change of -3.16%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 738 million in 2025Q2 from 778 million in 2025Q1 representing a change of -5.18%. This indicates a decrease in overall liabilities.
Total Current Liabilities: Total Current Liabilities decreased to 279 million in 2025Q2 from 294 million in 2025Q1 representing a change of -5.12%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2025Q2 from 0 in 2025Q1 representing a change of 5.68%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 374 million in 2025Q2 from 388 million in 2025Q1 representing a change of -3.77%. This indicates a reduction in overall debt burden.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001731348 | |||
| net change in cash | 21708000 | -209277000 | 110.37 |
| operating cash flow | -30905000 | 7906000 | -490.91 |
| free cash flow | -60154000 | -12894000 | -366.53 |
| capital expenditure | -29249000 | -20800000 | -40.62 |
| depreciation and amortization | 126913000 | 130149000 | -2.49 |
| deferred income tax | -38872000 | -31953000 | -21.65 |
| stock based compensation | 0 | 39595000 | -100.00 |
| accounts payables | 0 | 20044000 | -100.00 |
| inventory | 0 | -12934000 | 100.00 |
| acquisitions net | -52117000 | -26718000 | -95.06 |
| investments in property plant and equipment | -29249000 | -20800000 | -40.62 |
| net cash used for investing activites | 128349000 | -285111000 | 145.02 |
| debt repayment | -80906000 | -58246000 | -38.90 |
| common stock issued | 8619000 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -75187000 | 70158000 | -207.17 |
| cash at end of period | 228340000 | 206632000 | 10.51 |
| accounts receivables | 0 | 4168000 | -100.00 |
| cash at beginning of period | 206632000 | 415909000 | -50.32 |
Net Change in Cash: Net Change in Cash increased to 22 million in 2024 from -209 million in 2023 representing a change of 110.37%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -29 million in 2024 from -21 million in 2023 representing a change of -40.62%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024 from 40 million in 2023 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 20 million in 2023 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 0 million in 2024 from 4 million in 2023 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to -31 million in 2024 from 8 million in 2023 representing a change of -490.91%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -60 million in 2024 from -13 million in 2023 representing a change of -366.53%. This indicates a decrease in cash generated after accounting for capital expenditures.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0001731348 | |||
| operating cash flow | -40724000 | -35307000 | -15.34 |
| free cash flow | -40724000 | -42043000 | 3.14 |
| capital expenditure | 0 | -6736000 | 100.00 |
| depreciation and amortization | 0 | 31814000 | -100.00 |
| deferred income tax | 1147000 | 382000 | 200.26 |
| stock based compensation | 0 | 6917000 | -100.00 |
| accounts receivables | 0 | -2342000 | 100.00 |
| accounts payables | 0 | -8472000 | 100.00 |
| inventory | 0 | -12383000 | 100.00 |
| acquisitions net | 0 | 27999 | -100.00 |
| investments in property plant and equipment | 0 | -6736000 | 100.00 |
| net cash used for investing activites | -10725000 | -49395000 | 78.29 |
| debt repayment | -6842000 | -5882000 | -16.32 |
| common stock issued | 45045000 | 66472000 | -32.23 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 38203000 | 60590000 | -36.95 |
| net change in cash | -15488000 | -23154000 | 33.11 |
| cash at end of period | 189698000 | 205186000 | -7.55 |
| cash at beginning of period | 205186000 | 228340000 | -10.14 |
Net Change in Cash: Net Change in Cash increased to -15 million in 2025Q2 from -23 million in 2025Q1 representing a change of 33.11%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Free Cash Flow: Free Cash Flow increased to -41 million in 2025Q2 from -42 million in 2025Q1 representing a change of 3.14%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2025Q2 from 7 million in 2025Q1 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2025Q2 from 8 million in 2025Q1 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Operating Cash Flow: Operating Cash Flow decreased to -41 million in 2025Q2 from -35 million in 2025Q1 representing a change of -15.34%. This indicates that the company generated less cash from its core business operations.
Capital Expenditure: Capital Expenditure increased to 0 million in 2025Q2 from -7 million in 2025Q1 representing a change of 100.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 1 million in 2025Q2 from 0 million in 2025Q1 representing a change of 200.26%. This indicates that the company's tax liability for future periods has increased.
Accounts Receivables: Accounts Receivables increased to 0 in 2025Q2 from -2 million in 2025Q1 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q2 2025 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-05-31 | 2023-05-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2024 | 2023 | NaN |
| revenue per share | 1.06 | 1.01 | 4.68 |
| net income per share | -0.33 | -2.34 | 85.87 |
| operating cash flow per share | -0.04 | 0.01 | -425.29 |
| free cash flow per share | -0.08 | -0.02 | -288.21 |
| cash per share | 0.35 | 0.73 | -51.67 |
| book value per share | 4.64 | 5.39 | -13.96 |
| tangible book value per share | 0.7 | 0.56 | 24.31 |
| shareholders equity per share | 4.64 | 5.37 | -13.59 |
| interest debt per share | 0.59 | 0.98 | -39.82 |
| market cap | 1336769058.6 | 1032030923.63 | 29.53 |
| enterprise value | 1495746058.6 | 1415529923.63 | 5.67 |
| pe ratio | -5.46 | -0.72 | -662.95 |
| price to sales ratio | 1.69 | 1.65 | 2.96 |
| pocfratio | -43.25 | 130.54 | -133.14 |
| pfcf ratio | -22.22 | -80.04 | 72.24 |
| pb ratio | 0.39 | 0.31 | 24.74 |
| ptb ratio | 0.39 | 0.31 | 24.74 |
| ev to sales | 1.9 | 2.26 | -16.01 |
| enterprise value over ebitda | -20.53 | -1.59 | -1190.35 |
| ev to operating cash flow | -48.4 | 179.05 | -127.03 |
| ev to free cash flow | -24.87 | -109.78 | 77.35 |
| earnings yield | -0.18 | -1.4 | 86.89 |
| free cash flow yield | -0.04 | -0.01 | -260.17 |
| debt to equity | 0.11 | 0.18 | -36.79 |
| debt to assets | 0.09 | 0.14 | -33.04 |
| net debt to ebitda | -2.18 | -0.43 | -406.22 |
| current ratio | 2.27 | 1.79 | 26.88 |
| interest coverage | -3.55 | -100.81 | 96.48 |
| income quality | 0.14 | -0.01 | 2636.27 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.22 | 0.26 | -17.43 |
| research and ddevelopement to revenue | 0.0 | 0.0 | -25.99 |
| intangibles to total assets | 0.69 | 0.69 | 0.03 |
| capex to operating cash flow | -0.95 | 2.63 | -135.97 |
| capex to revenue | 0.04 | 0.03 | 11.78 |
| capex to depreciation | 0.23 | 0.16 | 44.21 |
| stock based compensation to revenue | 0 | 0.06 | -100.00 |
| graham number | 5.87 | 16.79 | -65.06 |
| roic | -0.04 | -0.33 | 88.48 |
| return on tangible assets | -0.19 | -1.09 | 82.67 |
| graham net net | -0.43 | -0.59 | 27.81 |
| working capital | 378540000 | 340050000 | 11.32 |
| tangible asset value | 518825000 | 347315000 | 49.38 |
| net current asset value | -100777000 | -204287000 | 50.67 |
| invested capital | 3877241000 | 3758286000 | 3.17 |
| average receivables | 93961000 | 90753000 | 3.53 |
| average payables | 88105500 | 69711500 | 26.39 |
| average inventory | 226319000 | 223040000 | 1.47 |
| days sales outstanding | 47.05 | 50.19 | -6.25 |
| days payables outstanding | 68.01 | 53.83 | 26.34 |
| days of inventory on hand | 162.68 | 152.45 | 6.71 |
| receivables turnover | 7.76 | 7.27 | 6.67 |
| payables turnover | 5.37 | 6.78 | -20.85 |
| inventory turnover | 2.24 | 2.39 | -6.29 |
| roe | -0.07 | -0.44 | 83.65 |
| capex per share | 0.04 | 0.03 | 17.01 |
ROE: Return on Equity (ROE) increased to -0.07 on 2024-05-31 from -0.44 on 2023-05-31, representing a change of 83.65%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -5.46 on 2024-05-31 from -0.72 on 2023-05-31, representing a change of -662.95%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 2.27 on 2024-05-31 from 1.79 on 2023-05-31, representing a change of 26.88%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.11 on 2024-05-31 from 0.18 on 2023-05-31, representing a change of -36.79%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-11-30 Q2 | 2024-08-31 Q1 | Q/Q change % | |
|---|---|---|---|
| TLRY | |||
| calendar year | 2025 | 2025 | NaN |
| revenue per share | 0.24 | 0.23 | 6.73 |
| net income per share | -0.1 | -0.04 | -120.37 |
| operating cash flow per share | -0.05 | -0.04 | -16.74 |
| free cash flow per share | -0.05 | -0.05 | 1.96 |
| cash per share | 0.29 | 0.32 | -8.84 |
| book value per share | 3.99 | 3.98 | 0.34 |
| tangible book value per share | 0.68 | 0.65 | 5.05 |
| shareholders equity per share | 4.02 | 3.97 | 1.06 |
| interest debt per share | 0.44 | 0.45 | -3.04 |
| market cap | 1159065914.42 | 1497010655.88 | -22.57 |
| enterprise value | 1343158914.42 | 1680245655.88 | -20.06 |
| pe ratio | -3.4 | -9.56 | 64.44 |
| price to sales ratio | 5.49 | 7.48 | -26.58 |
| pocfratio | -28.46 | -42.4 | 32.87 |
| pfcf ratio | -28.46 | -35.61 | 20.07 |
| pb ratio | 0.33 | 0.43 | -22.46 |
| ptb ratio | 0.33 | 0.43 | -22.46 |
| ev to sales | 6.37 | 8.4 | -24.19 |
| enterprise value over ebitda | -32.43 | 212.96 | -115.23 |
| ev to operating cash flow | -32.98 | -47.59 | 30.69 |
| ev to free cash flow | -32.98 | -39.96 | 17.47 |
| earnings yield | -0.07 | -0.03 | -181.22 |
| free cash flow yield | -0.04 | -0.03 | -25.10 |
| debt to equity | 0.11 | 0.11 | -3.62 |
| debt to assets | 0.09 | 0.09 | -2.16 |
| net debt to ebitda | -4.44 | 23.22 | -119.14 |
| current ratio | 2.54 | 2.47 | 2.70 |
| interest coverage | -5.44 | -3.72 | -46.30 |
| income quality | 0 | 1.02 | -100.00 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.22 | 0.22 | -1.18 |
| research and ddevelopement to revenue | 0.0 | 0.0 | -45.81 |
| intangibles to total assets | 0.68 | 0.68 | -0.11 |
| capex to operating cash flow | 0 | -0.19 | 100.00 |
| capex to revenue | 0 | 0.03 | -100.00 |
| capex to depreciation | 0 | 0.21 | -100.00 |
| stock based compensation to revenue | 0 | 0.03 | -100.00 |
| graham number | 2.98 | 2.0 | 49.23 |
| roic | -0.01 | -0.01 | -16.84 |
| return on tangible assets | -0.06 | -0.03 | -120.83 |
| graham net net | -0.31 | -0.33 | 5.77 |
| working capital | 428815000 | 432334000 | -0.81 |
| tangible asset value | 586368000 | 564932000 | 3.79 |
| net current asset value | -30807000 | -52570000 | 41.40 |
| invested capital | 3868717000 | 3923128000 | -1.39 |
| average receivables | 108388000 | 102866000 | 5.37 |
| average payables | 100472500 | 103630000 | -3.05 |
| average inventory | 265151000 | 258191000 | 2.70 |
| days sales outstanding | 48.1 | 46.81 | 2.76 |
| days payables outstanding | 59.55 | 65.33 | -8.84 |
| days of inventory on hand | 159.89 | 169.49 | -5.67 |
| receivables turnover | 1.87 | 1.92 | -2.69 |
| payables turnover | 1.51 | 1.38 | 9.70 |
| inventory turnover | 0.56 | 0.53 | 6.01 |
| roe | -0.02 | -0.01 | -118.06 |
| capex per share | 0 | 0.01 | -100.00 |
ROE: Return on Equity (ROE) decreased to -0.02 on 2024-11-30 Q2 from -0.01 on 2024-08-31 Q1, representing a change of -118.06%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -3.40 on 2024-11-30 Q2 from -9.56 on 2024-08-31 Q1, representing a change of 64.44%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 2.54 on 2024-11-30 Q2 from 2.47 on 2024-08-31 Q1, representing a change of 2.70%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.11 on 2024-11-30 Q2 from 0.11 on 2024-08-31 Q1, representing a change of -3.62%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-22 08:20:00
MoneyShow presents top investment ideas for 2025 from their contributors. This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up stocks with turnaround potential, along with some speculative plays and ETFs. Part 5 includes Boeing, Warby Parker, SentinelOne, Dutch Bros, Tilray Brands and SFL, among others.
Sentiment: Neutral
Publish Date: 2025-01-22 05:45:00
During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis stocks in the industry is Tilray Brands (TLRY -2.50%), and during that stretch, its valuation has crumbled, falling by a staggering 94%.
Sentiment: Positive
Publish Date: 2025-01-17 08:43:46
Marijuana stock investing in 2025 may be easier than you think. With a new year just getting started volatility could change to upward momentum. As 2025 is underway the chances to vote on bills and change the cannabis industry are upon us in the USA. In addition to other global regions looking to enter the space. What initially makes it easier is currently the sector is currently trading at low entry points.
Sentiment: Positive
Publish Date: 2025-01-14 21:39:52
Any investor hoping to reap the rewards by holding marijuana companies must be a shiny-eyed optimist at this point. Weed companies are among the worst performers on the stock exchange since they are constantly barraged by headwinds in North America.
Sentiment: Negative
Publish Date: 2025-01-14 10:18:44
Tilray shares fell over 10% after another revenue miss and significant cash burn, raising concerns about the stock setting new lows. Despite some growth in beverage revenues, overall financials remain bleak, with continued losses and significant shareholder dilution. If cash burn doesn't improve, investors will be significantly diluted even more, potentially leading to a reverse split if the stock falls below $1.
Sentiment: Positive
Publish Date: 2025-01-10 15:19:20
Tilray Brands (NASDAQ:TLRY) shares plunged more than 11% following the release of its fiscal second quarter 2025 earnings report, where sales fell short of estimates. The company reported net revenue of $211 million for the quarter, marking a 9% increase year-over-year but falling short of analysts' expectations of $216.3 million.
Sentiment: Positive
Publish Date: 2025-01-10 13:08:01
Tilray Brands, Inc. (NASDAQ:TLRY ) Q2 2025 Earnings Conference Call January 10, 2025 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs & Communications Officer Irwin Simon - Chairman & Chief Executive Officer Carl Merton - Chief Financial Officer Ty Gilmore - President, Tilray Beverages North America Blair MacNeil - President, Tilray Canada Denise Faltischek - Chief Strategy Officer & Head, International Conference Call Participants Kaumil Gajrawala - Jefferies Robert Moskow - TD Cowen Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Bill Kirk - Roth MKM Matt Bottomley - Canaccord Genuity Pablo Zuanic - Zuanic & Associates Michael Lavery - Piper Sandler Operator Thank you for joining us for today's conference call to discuss Tilray Brands' Financial Results for the Second Quarter ended November 30, 2024. All lines have been placed on mute to prevent any background noise.
Sentiment: Negative
Publish Date: 2025-01-10 11:31:38
Tilray Brands (TLRY -11.56%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report.
Sentiment: Positive
Publish Date: 2025-01-10 10:31:23
While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended November 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Sentiment: Neutral
Publish Date: 2025-01-10 09:43:26
On Friday, Tilray Brands, Inc's. TLRY second-quarter net revenue increased 9% year-over-year to $210.95 million, missing the consensus of $216.91 million.
Sentiment: Negative
Publish Date: 2025-01-10 09:11:07
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to break-even earnings per share a year ago.
Sentiment: Negative
Publish Date: 2025-01-10 08:29:00
The beer and cannabis company's revenue fell short of analyst estimates.
Sentiment: Positive
Publish Date: 2025-01-10 07:00:00
Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments
Sentiment: Negative
Publish Date: 2025-01-08 09:00:00
Tilray Brands has consistently missed analyst estimates and diluted shares via acquisitions and cash burn. The upcoming fiscal Q2 results are expected to show revenue growth but lack clarity on organic sales due to numerous acquisitions. Despite reporting sales growth, Tilray is still reporting losses due to low gross margins and a complex business structure.
Sentiment: Positive
Publish Date: 2025-01-07 10:00:32
The Canadian cannabis market remains a focal point for investors, driven by innovation and expansion into U.S. and global markets. As the U.S. cannabis industry is projected to surpass $41 billion in annual sales by 2025, Canadian companies are positioning themselves for growth. Recent legislative developments in the U.S., including discussions about federal legalization, have bolstered market optimism. These changes could pave the way for Canadian firms to expand operations or form strategic partnerships. Notably, companies like Tilray and Canopy Growth are diversifying portfolios to include U.S. hemp, CBD, and beverage markets, showcasing their adaptability.
Sentiment: Positive
Publish Date: 2025-01-06 07:00:00
NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical , a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg highlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis across the global medical cannabis industry.
Sentiment: Negative
Publish Date: 2025-01-06 01:07:12
The Tilray Brands stock price has crawled back in the past few days, rising from the December low of $1.15 to $1.45. This mini-rebound will be put to test when the cannabis company publishes its financial results later this week.
Sentiment: Positive
Publish Date: 2025-01-03 19:36:27
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.45, denoting a -0.68% change from the preceding trading day.
Sentiment: Negative
Publish Date: 2025-01-02 17:47:00
NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025.
Sentiment: Positive
Publish Date: 2025-01-02 14:40:57
Irwin Simon, Tilray CEO, discusses outlooks on the beverage and cannabis industries.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
